Focused Ultrasound and Gemcitabine in Breast Cancer
Clinical trial NCT04796220 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04796220
- Sponsor
- Patrick Dillon, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2029-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.